Integrated Proteins Ltd
Incorporated in 1992, Integrated Proteins Ltd is in the business of trading in various oil seeds and agri commodities.[1]
- Market Cap ₹ 94.2 Cr.
- Current Price ₹ 50.3
- High / Low ₹ 52.8 / 20.7
- Stock P/E 392
- Book Value ₹ 10.9
- Dividend Yield 0.00 %
- ROCE 1.87 %
- ROE 1.76 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 4.63 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -10.8%
- Promoter holding is low: 2.23%
- Company has a low return on equity of 1.52% over last 3 years.
- Working capital days have increased from 64.2 days to 339 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.09 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.24 | 21.50 | 25.69 | |
| 0.12 | 0.14 | 0.15 | 0.09 | 0.09 | 0.14 | 0.11 | 0.10 | 0.08 | 0.26 | 0.36 | 21.40 | 25.44 | |
| Operating Profit | -0.05 | -0.05 | -0.07 | -0.09 | -0.09 | -0.14 | -0.11 | -0.10 | -0.08 | -0.09 | -0.12 | 0.10 | 0.25 |
| OPM % | -71.43% | -55.56% | -87.50% | -52.94% | -50.00% | 0.47% | 0.97% | ||||||
| 0.19 | 0.17 | 0.18 | 0.20 | 0.18 | 0.17 | 0.16 | 0.16 | 0.16 | 0.16 | 0.25 | 0.23 | 0.09 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 |
| Profit before tax | 0.11 | 0.09 | 0.08 | 0.08 | 0.06 | 0.00 | 0.02 | 0.03 | 0.05 | 0.04 | 0.10 | 0.32 | 0.32 |
| Tax % | 0.00% | 0.00% | 0.00% | 50.00% | 83.33% | 50.00% | 33.33% | 40.00% | 25.00% | 10.00% | 21.88% | ||
| 0.11 | 0.09 | 0.08 | 0.05 | 0.01 | 0.02 | 0.01 | 0.02 | 0.04 | 0.03 | 0.09 | 0.25 | 0.24 | |
| EPS in Rs | 0.30 | 0.24 | 0.22 | 0.14 | 0.03 | 0.05 | 0.03 | 0.05 | 0.11 | 0.08 | 0.24 | 0.78 | 0.68 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 73% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 10176% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 82% |
| 3 Years: | 71% |
| TTM: | 300% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 73% |
| 3 Years: | 59% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.20 |
| Reserves | -1.20 | -1.12 | -1.03 | -0.98 | -0.98 | -1.09 | -1.09 | -1.07 | -1.03 | -1.00 | -0.91 | 16.60 | 17.15 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.08 | 0.19 | 0.04 | 3.90 | 0.09 | |
| 0.16 | 0.16 | 0.18 | 0.05 | 0.10 | 0.13 | 0.12 | 0.13 | 0.12 | 0.10 | 0.08 | 8.35 | 8.16 | |
| Total Liabilities | 2.48 | 2.56 | 2.67 | 2.59 | 2.64 | 2.56 | 2.55 | 2.61 | 2.69 | 2.81 | 2.73 | 32.37 | 28.60 |
| 0.67 | 0.64 | 0.61 | 0.58 | 0.55 | 0.52 | 0.49 | 0.47 | 0.44 | 0.41 | 0.42 | 0.05 | 0.05 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.10 | 0.10 | 0.15 | 0.00 | 0.00 |
| 1.80 | 1.91 | 2.06 | 2.01 | 2.09 | 2.04 | 2.06 | 2.03 | 2.15 | 2.30 | 2.16 | 32.32 | 28.55 | |
| Total Assets | 2.48 | 2.56 | 2.67 | 2.59 | 2.64 | 2.56 | 2.55 | 2.61 | 2.69 | 2.81 | 2.73 | 32.37 | 28.60 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | -0.07 | -0.08 | -0.21 | -0.24 | 0.14 | -0.16 | -0.09 | -0.09 | -0.12 | -0.06 | -23.56 | |
| -0.30 | 0.08 | 0.18 | 0.18 | 0.18 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 | 0.34 | 2.47 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 | 0.03 | 0.05 | 0.11 | 0.16 | 21.12 | |
| Net Cash Flow | -0.22 | 0.01 | 0.10 | -0.02 | -0.07 | 0.08 | -0.13 | -0.03 | -0.04 | -0.01 | 0.43 | 0.03 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52.14 | 0.00 | 136.88 | 0.00 | 0.00 | 0.00 | ||||||
| Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 52.14 | 0.00 | 136.88 | 0.00 | 0.00 | 0.00 | ||||||
| Working Capital Days | -834.29 | -608.33 | -730.00 | -85.88 | -60.83 | 339.20 | ||||||
| ROCE % | 4.52% | 3.81% | 3.27% | 3.18% | 2.36% | 0.00% | 0.82% | 1.22% | 1.98% | 1.52% | 0.37% | 1.87% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Benefit Expenses ₹ Lakhs |
|
|||||||||||
| Net Block of Property, Plant & Equipment ₹ Lakhs |
||||||||||||
| Installed Capacity (Solvent Extraction) MT per annum |
||||||||||||
| Trading Volume (Agri-Commodities) MT |
||||||||||||
Documents
Announcements
-
Clarification On Price Movement
10 Mar - 10/03/2026: Informs BSE (Scrip 519606) no undisclosed price-sensitive information; price movement market-driven.
-
Clarification sought from Integrated Proteins Ltd
2 Mar - Exchange has sought clarification from Integrated Proteins Ltd on March 2, 2026 with reference to significant movement in price, in order to ensure that investors …
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Feb - Submission of copies of News Paper Advertisement
-
Outcome Of The Meeting Of The Board Held On Thursday, 12Th February, 2026 Pursuant To Regulation 30 & 33 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015.
12 Feb - Approved unaudited results for quarter and nine months ended 31/12/2025; Rs1744.88 lakh funds, limited review.
-
Board Meeting Outcome for Outcome Of The Meeting Of The Board Held On Thursday, 12Th February, 2026 Pursuant To Regulation 30 & 33 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015.
12 Feb - Board approved unaudited Q3 and nine-month results to 31 Dec 2025; Rs1,744.88 lakh raised.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
IPL is engaged in the business of manufacturing, trading, and processing various oilseeds. There was an operational shift in the business as:
a) The company ceased operations in the solvent extraction of oilseeds.
b) In FY24, the company explored one of its main objectives and commenced trading in agri
commodities.